We don't know that.
I will make two comments. When the minister announced that, she said it was based on advice from the vaccine task force. We were involved in that advice.
Over the course of our discussions, we have met with our counterparts in the U.K., New Zealand, Australia. We've had discussions with Germany and France, and so on. It has been somewhat remarkable how there has been a similar approach, in terms of the portfolio approach. Among the companies we've been working with, there's a fair degree of overlap, so one might anticipate that they've been doing the same.